HomeCompareDFEM vs JNJ

DFEM vs JNJ: Dividend Comparison 2026

DFEM yields 2.20% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DFEM wins by $2.9K in total portfolio value
10 years
DFEM
DFEM
● Live price
2.20%
Share price
$34.27
Annual div
$0.75
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.9K
Annual income
$253.57
Full DFEM calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — DFEM vs JNJ

📍 DFEM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDFEMJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DFEM + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DFEM pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DFEM
Annual income on $10K today (after 15% tax)
$186.97/yr
After 10yr DRIP, annual income (after tax)
$215.53/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $488.08/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DFEM + JNJ for your $10,000?

DFEM: 50%JNJ: 50%
100% JNJ50/50100% DFEM
Portfolio after 10yr
$21.5K
Annual income
$540.67/yr
Blended yield
2.52%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

DFEM
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DFEM buys
0
JNJ buys
0
No recent congressional trades found for DFEM or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDFEMJNJ
Forward yield2.20%3.36%
Annual dividend / share$0.75$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$22.9K$20.0K
Annual income after 10y$253.57$827.78
Total dividends collected$2.4K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: DFEM vs JNJ ($10,000, DRIP)

YearDFEM PortfolioDFEM Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,920$219.97$10,676$355.77+$244.00DFEM
2$11,909$224.49$11,407$389.39+$502.00DFEM
3$12,971$228.80$12,198$426.53+$773.00DFEM
4$14,112$232.91$13,056$467.62+$1.1KDFEM
5$15,337$236.82$13,987$513.12+$1.4KDFEM
6$16,651$240.53$14,998$563.56+$1.7KDFEM
7$18,061$244.06$16,098$619.52+$2.0KDFEM
8$19,572$247.40$17,295$681.69+$2.3KDFEM
9$21,193$250.57$18,599$750.82+$2.6KDFEM
10$22,930$253.57$20,022$827.78+$2.9KDFEM

DFEM vs JNJ: Complete Analysis 2026

DFEMStock

The Portfolio is designed to purchase a broad and diverse group of securities associated with emerging markets, which may include frontier markets (emerging market countries in an earlier stage of development). As a non-fundamental policy, under normal circumstances, the Portfolio will invest at least 80% of its net assets in emerging markets equity investments that are defined in the prospectus as Approved Market securities.

Full DFEM Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this DFEM vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DFEM vs SCHDDFEM vs JEPIDFEM vs ODFEM vs KODFEM vs MAINDFEM vs ABBVDFEM vs MRKDFEM vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.